BRTX vs ETR · rev $401.0K vs P/E 28, rev $12.95B
BioRestorative Therapies Inc (BRTX) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
BRTX currently screens at market cap $10.2M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the BRTX and ETR stock pages for the full models.
Not investment advice.